Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

Authors

  • W. J. A. Witlox Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands
  • B. L. T. Ramaekers Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands
  • H. J. M. Groen Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands
  • A. M. Dingemans Department of Pulmonology, Maastricht University Medical Center, GROW Research Institute, Maastricht, The Netherlands
  • J. Praag Department of Radiation Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
  • J. Belderbos Department of Radiation Oncology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
  • V. van der Noort Department of Biometrics, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
  • H. van Tinteren Department of Biometrics, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
  • M. A. Joore Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands;  Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands
  • D. K. M. De Ruysscher Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center, GROW Research Institute, Maastricht, The Netherlands

DOI:

https://doi.org/10.1080/0284186X.2019.1629016

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2019-10-03

How to Cite

Witlox, W. J. A., Ramaekers, B. L. T., Groen, H. J. M., Dingemans, A. M., Praag, J., Belderbos, J., … De Ruysscher, D. K. M. (2019). Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study. Acta Oncologica, 58(10), 1528–1531. https://doi.org/10.1080/0284186X.2019.1629016

Issue

Vol. 58 No. 10 (2019): Acta Oncologica

Section

Articles